Overexpression of P150, a part of the large subunit of the eukaryotic translation initiation factor 3, in colon cancer

Anticancer Research

Volumn 30, Issue 4, 2010, Pages 1047-1055

  Haybaeck, J ^a,b   O'Connor, T ^a   Spilka, R ^c   Spizzo, G ^d   Ensinger, Ch ^d   Mikuz, G ^d   Brunhuber, T ^c   Vogetseder, A ^d   Theurl, I ^d   Salvenmoser, W ^e   Draxl, H ^f   Banziger R ^g   Bachmann, F ^g   Schafer G ^c   Burger, M ^g   Obrist, Peter ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c Hospital Zams   (Austria)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY OF INNSBRUCK   (Austria)

^f University of Basel ^*  (Austria)

^g UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Actin; Electron microscopy; Histochemistry; Tubulin

Indexed keywords

INITIATION FACTOR 3; P150 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GRADING; COLON CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGOLD LABELING; IMMUNOHISTOCHEMISTRY; LASER SCANNING CYTOMETRY; LYMPH NODE METASTASIS; MOLECULAR CLONING; MUCOSA; POLYSOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PURIFICATION; SEQUENCE HOMOLOGY; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; EUKARYOTIC INITIATION FACTOR-3; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; MIDDLE AGED; NEOPLASM STAGING;

EID: 77953766170     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Alitalo K and Schwab M: Oncogene amplification in tumor cells. Adv Cancer Res 47: 235-281, 1986.
2. Bachmann F, Banziger R and Burger MM: Cloning of a novel protein overexpressed in human mammary carcinoma. Cancer Res 57: 988-994, 1997. (Pubitemid 27098028)
3. Benne R and Hershey JW: The mechanism of action of protein synthesis initiation factors from rabbit reticulocytes. J Biol Chem 253: 3078-3087, 1978. (Pubitemid 8353180)
4. Chaudhuri J, Chakrabarti A and Maitra U: Biochemical characterization of mammalian translation initiation factor 3 (eIF3). Molecular cloning reveals that p110 subunit is the mammalian homologue of Saccharomyces cerevisiae protein Prt1. J Biol Chem 272: 30975-30983, 1997.
5. Chen G and Burger MM: p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus. Int J Cancer 84: 95-100, 1999.
6. Chudinova EM, Ivanov PA and Nadezhdina ES: Large subunit of translation initiation factor-3 p170 contains potentially functional nuclear localization signals. Mol Biol (Mosk) 38: 684-691, 2004. (Pubitemid 44406521)
7. Delias A, Torhorst J, Bachmann F, Banziger R, Schultheiss E and Burger MM: Expression of p150 in cervical neoplasia and its potential value in predicting survival. Cancer 83: 1376-1383, 1998.
8. Dever TE, Chen JJ, Barber GN, Cigan AM, Feng L, Donahue TF, London IM, Katze MG and Hinnebusch AG: Mammalian eukaryotic initiation factor 2 alpha kinases functionally substitute for GCN2 protein kinase in the GCN4 translational control mechanism of yeast. Proc Natl Acad Sci USA 90: 4616-4620, 1993.
9. Dever TE, Feng L, Wek RC, Cigan AM, Donahue TF and Hinnebusch AG: Phosphorylation of initiation factor 2 alpha by protein kinase GCN2 mediates gene-specific translational control of GCN4 in yeast. Cell 68: 585-596, 1992.
10. Dong Z, Liu LH, Han B, Pincheira R and Zhang JT: Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth. Oncogene 23: 3790-3801, 2004.
11. Dong Z and Zhang JT: EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression. Mol Biol Cell 14: 3942-3951, 2003.
12. Dong Z and Zhang JT: Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer. Crit Rev Oncol Hematol 59: 169-180, 2006.
13. Donze O, Jagus R, Koromilas AE, Hershey JW and Sonenberg N: Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J 14: 3828-3834, 1995.
14. Fukuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H and Igarashi K: Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 57: 5041-5044, 1997.
15. Garcia-Barrio MT, Naranda T, Vazquez de Aldana CR, Cuesta R, Hinnebusch AG, Hershey JW and Tamame M: GCD10, a translational repressor of GCN4, is the RNA-binding subunit of eukaryotic translation initiation factor-3. Genes Dev 9: 1781-1796, 1995.
16. Goumans H, Thomas A, Verhoeven A, Voorma HO and Benne R: The role of eIF-4C in protein synthesis initiation complex formation. Biochim Biophys Acta 608: 39-46, 1980.
17. Graff JR, Boghaert ER, De Benedetti A, Tudor DL, Zimmer CC, Chan SK and Zimmer SG: Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts. Int J Cancer 60: 255-263, 1995.
18. Hanachi P, Hershey JW and Vornlocher HP: Characterization of the p33 subunit of eukaryotic translation initiation factor-3 from Saccharomyces cerevisiae. J Biol Chem 274: 8546-8553, 1999.
19. Hannig EM: Protein synthesis in eukaryotic organisms: new insights into the function of translation initiation factor eIF-3. Bioessays 17: 915-919, 1995.
20. Hershey JW, Asano K, Naranda T, Vornlocher HP, Hanachi P and Merrick WC: Conservation and diversity in the structure of translation initiation factor EIF3 from humans and yeast. Biochimie 78: 903-907, 1996.
21. Johnson KR, Merrick WC, Zoll WL and Zhu Y: Identification of cDNA clones for the large subunit of eukaryotic translation initiation factor 3. Comparison of homologues from human, Nicotiana tabacum, Caenorhabditis elegans, and Saccharomyces cerevisiae. J Biol Chem 272: 7106-7113, 1997.
22. Joswig G, Petzelt C and Werner D: Murine cDNAs coding for the centrosomal antigen centrosomin A. J Cell Sci 98(Pt 1): 37-43, 1991. (Pubitemid 21924952)
23. Kevil C, Carter P, Hu B and DeBenedetti A: Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene 11: 2339-2348, 1995. (Pubitemid 26008411)
24. Kevil CG, De Benedetti A, Payne DK, Coe LL, Laroux FS and Alexander JS: Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. Int J Cancer 65: 785-790, 1996.
25. Kyrpides NC and Woese CR: Universally conserved translation initiation factors. Proc Natl Acad Sci USA 95: 224-228, 1998.
26. Lamphear BJ, Kirchweger R, Skern T and Rhoads RE: Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. J Biol Chem 270: 21975-21983, 1995.
27. Lazaris-Karatzas A, Montine KS and Sonenberg N: Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345: 544-547, 1990. (Pubitemid 120014983)
28. Lazaris-Karatzas A, Smith MR, Frederickson RM, Jaramillo ML, Liu YL, Kung HF and Sonenberg N: Ras mediates translation initiation factor 4E-induced malignant transformation. Genes Dev 6: 1631-1642, 1992.
29. Li BD, Liu L, Dawson M and De Benedetti A: Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma. Cancer 79: 2385-2390, 1997.
30. Liu Z, Dong Z, Yang Z, Chen Q, Pan Y, Yang Y, Cui P, Zhang X and Zhang JT: Role of eIF3A (eIF3 p170) in intestinal cell differentiation and its association with early development. Differentiation 75: 652-661, 2007.
31. Mader S, Lee H, Pause A and Sonenberg N: The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins. Mol Cell Biol 15: 4990-4997, 1995.
32. Mazia D: The chromosome cycle and the centrosome cycle in the mitotic cycle. Int Rev Cytol 100: 49-92, 1987.
33. Merighi A, Polak JM, Fumagalli G and Theodosis DT: Ultrastructural localization of neuropeptides and GABA in rat dorsal horn: a comparison of different immunogold labeling techniques. J Histochem Cytochem 37: 529-540, 1989. (Pubitemid 19086850)
34. Methot N, Rom E, Olsen H and Sonenberg N: The human homologue of the yeast Prt1 protein is an integral part of the eukaryotic initiation factor 3 complex and interacts with p170. J Biol Chem 272: 1110-1116, 1997.
35. Methot N, Song MS and Sonenberg N: A region rich in aspartic acid, arginine, tyrosine, and glycine (DRYG) mediates eukaryotic initiation factor 4B (eIF4B) self-association and interaction with eIF3. Mol Cell Biol 16: 5328-5334, 1996.
36. Methot N, Song MS and Sonenberg N: A region rich in aspartic acid, arginine, tyrosine, and glycine (DRYG) mediates eukaryotic initiation factor 4B (eIF4B) self-association and interaction with eIF3. Mol Cell Biol 16: 5328-5334, 1996. (Pubitemid 26315051)
37. Nakai Y, Shiratsuchi A, Manaka J, Nakayama H, Takio K, Zhang JT, Suganuma T and Nakanishi Y: Externalization and recognition by macrophages of large subunit of eukaryotic translation initiation factor 3 in apoptotic cells. Exp Cell Res 309: 137-148, 2005.
38. Naranda T, MacMillan SE and Hershey JW: Purified yeast translational initiation factor eIF-3 is an RNA-binding protein complex that contains the PRT1 protein. J Biol Chem 269: 32286-32292, 1994.
39. Noske A, Lindenberg JL, Darb-Esfahani S, Weichert W, Buckendahl AC, Roske A, Sehouli J, Dietel M and Denkert C: Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-elF-4E and prognosis. Oncol Rep 20: 1409-1417, 2008.
40. Nupponen NN, Porkka K, Kakkola L, Tanner M, Persson K, Borg A, Isola J and Visakorpi T: Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am J Pathol 154: 1777-1783, 1999.
41. Petzelt C, Joswig G, Mincheva A, Lichter P, Stammer H and Werner D: The centrosomal protein centrosomin A and the nuclear protein centrosomin B derive from one gene by post-transcriptional processes involving RNA editing. J Cell Sci 110(Pt 20): 2573-2578, 1997.
42. Pincheira R, Chen Q and Zhang JT: Identification of a 170-kDa protein overexpressed in lung cancers. Br J Cancer 84: 1520-1527, 2001.
43. Rhoads RE: Regulation of eukaryotic protein synthesis by initiation factors. J Biol Chem 268: 3017-3020, 1993. (Pubitemid 23070916)
44. Rosenwald IB, Chen JJ, Wang S, Savas L, London IM and Pullman J: Up-regulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis. Oncogene 18: 2507-2517, 1999.
45. Rosenwald IB, Lazaris-Karatzas A, Sonenberg N and Schmidt EV: Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 13: 7358-7363, 1993.
46. Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KJ and Schmidt EV: Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. Proc Natl Acad Sci USA 90: 6175-6178, 1993.
47. Shantz LM, Hu RH and Pegg AE: Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E. Cancer Res 56: 3265-3269, 1996.
48. Spurr AR: A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res 26: 31-43, 1969.
49. Trachsel H and Staehelin T: Initiation of mammalian protein synthesis. The multiple functions of the initiation factor eIF-3. Biochim Biophys Acta 565: 305-314, 1979.
50. Verlhac MH, Chen RH, Hanachi P, Hershey JW and Derynck R: Identification of partners of TIF34, a component of the yeast eIF3 complex, required for cell proliferation and translation initiation. EMBO J 16: 6812-6822, 1997.
51. Wang S, Rosenwald IB, Hutzler MJ, Pihan GA, Savas L, Chen JJ and Woda BA: Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol 155: 247-255, 1999.
52. Wittekind C and Oberschmid B: Gastrointestinal tumors: New N classification of the UICC. Chirurg 81: 95-98, 2010.
53. Yang GF, Xie D, Liu JH, Luo JH, Li LJ, Hua WF, Wu HM, Kung HF, Zeng YX and Guan XY: Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma. Gynecol Oncol 112: 314-318, 2009.